The Role of NMP22 and CSTB Levels in Predicting Postoperative Recurrence of Bladder Cancer
Summary
Preoperative NMP22 and CSTB conveying is hardly interrelated to postoperative recurrence of bladder carcinoma and has certain appraisal worth for postoperative recurrence of bladder carcinoma, and the combined testing of the two has a taller appraisal worth. NMP22 combined with CSTB detection will help to detect postoperative recurrence of bladder cancer and formulate effective treatment measures in time. Copyright © 2022 Changkun Huang et al.
| Authors | Huang C, Ai X, Hu L, Ren D |
|---|---|
| Journal | Journal of immunology research |
| Publication Date | 2022;2022:6735310 |
| PubMed | 35647202 |
| PubMed Central | PMC9135568 |
| DOI | 10.1155/2022/6735310 |